|
Secondary prevention
Citations 161-170 of 240 total displayed.
|
Past content
(since Jun 2001):
|
- Articles
Potential Consequences for Recruitment, Power, and External Validity of Requirements for Additional Risk Factors for Eligibility in Randomized Controlled Trials in Secondary Prevention of Stroke
- Sally C. Howard, Ale Algra, Charles P. Warlow, and Peter M. Rothwell
Stroke published December 8, 2005, doi:10.1161/01.STR.0000195125.59349.23
[Abstract]
- Original Contributions
Vitamin Intervention for Stroke Prevention Trial: An Efficacy Analysis
- J. David Spence, Heejung Bang, Lloyd E. Chambless, and Meir J. Stampfer
Stroke 2005;36:2404-2409; published online before print as doi:10.1161/01.STR.0000185929.38534.f3
[Abstract]
[Full text]
- Articles
Vitamin Intervention for Stroke Prevention Trial. An Efficacy Analysis
- J. David Spence, Heejung Bang, Lloyd E. Chambless, and Meir J. Stampfer
Stroke published October 20, 2005, doi:10.1161/01.STR.0000185929.38534.f3
[Abstract]
- Original Contributions
Culprit Factors for the Failure of Well-Conducted Warfarin Therapy to Prevent Ischemic Events in Patients With Atrial Fibrillation: The Role of Homocysteine
- Daniela Poli, Emilia Antonucci, Emanuele Cecchi, Rossella Marcucci, Agatina Alessandrello Liotta, Anna Paola Cellai, Meri Lenti, Gian Franco Gensini, Rosanna Abbate, and Domenico Prisco
Stroke 2005;36:2159-2163; published online before print as doi:10.1161/01.STR.0000183620.06179.7b
[Abstract]
[Full text]
- Original Contributions
Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
- Hisatomi Arima, Robert G. Hart, Sam Colman, John Chalmers, Craig Anderson, Anthony Rodgers, Mark Woodward, Stephen MacMahon, Bruce Neal for the PROGRESS Collaborative Group
Stroke 2005;36:2164-2169; published online before print as doi:10.1161/01.STR.0000181115.59173.42
[Abstract]
[Full text]
- Articles
Culprit Factors for the Failure of Well-Conducted Warfarin Therapy to Prevent Ischemic Events in Patients With Atrial Fibrillation. The Role of Homocysteine
- Daniela Poli, Emilia Antonucci, Emanuele Cecchi, Rossella Marcucci, Agatina Alessandrello Liotta, Anna Paola Cellai, Meri Lenti, Gian Franco Gensini, Rosanna Abbate, and Domenico Prisco
Stroke published September 22, 2005, doi:10.1161/01.STR.0000183620.06179.7b
[Abstract]
- Articles
Perindopril-Based Blood Pressure-lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
- Hisatomi Arima, Robert G. Hart, Sam Colman, John Chalmers, Craig Anderson, Anthony Rodgers, Mark Woodward, Stephen MacMahon, Bruce Neal for the PROGRESS Collaborative Group
Stroke published September 1, 2005, doi:10.1161/01.STR.0000181115.59173.42
[Abstract]
- Original Contributions
Evidence for Age and Sex Differences in the Secondary Prevention of Stroke in Scottish Primary Care
- C.R. Simpson, C. Wilson, P.C. Hannaford, and D. Williams
Stroke 2005;36:1771-1775; published online before print as doi:10.1161/01.STR.0000173398.99163.9e
[Abstract]
[Full text]
- Articles
Evidence for Age and Sex Differences in the Secondary Prevention of Stroke in Scottish Primary Care
- C. R. Simpson, C. Wilson, P. C. Hannaford, and D. Williams
Stroke published July 21, 2005, doi:10.1161/01.STR.0000173398.99163.9e
[Abstract]
- Original Contributions
Gender Differences in Outcome of Conservatively Treated Patients With Asymptomatic High Grade Carotid Stenosis
- Petra Dick, Camillo Sherif, Schila Sabeti, Jasmin Amighi, Erich Minar, and Martin Schillinger
Stroke 2005;36:1178-1183; published online before print as doi:10.1161/01.STR.0000166056.04922.f2
[Abstract]
[Full text]
|
|
